The advertisement promotes REXULTI (brexpiprazole) as a treatment for agitation related to Alzheimer's disease, while highlighting important safety warnings and limitations regarding its use in elderly patients with dementia-related psychosis.
Creative Information
| CID: | a1acecaa-9a63-4daa-8f79-9ae5d5343477 |
| CRID: | 29_680222045 |
| Domain: | rexultihcp.com |
| Seat: | Xandr |
| Size: | 300x250 |
| Bid: | $18.36 |
| Timestamp: | 11/4/2025, 3:57:20 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/4/2025, 4:11:07 PM | 6.13s | |
| adomain_analysis | success | 11/4/2025, 5:06:59 PM | 2.99s | |
| adomain_capture | success | 11/4/2025, 5:06:55 PM | 9.80s | |
| ad_render | success | 11/4/2025, 4:11:00 PM | 24.94s | |
| brand_mapping | success | 11/4/2025, 4:11:01 PM | 0.93s | |
Analysis Results
Ad Format: banner
Brands: Rexulti
Sensitive:Misleading Health ClaimsUnverified Medical TreatmentsPharmaceutical Products
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1501.48 KB | ||||||||||||||||||||||
| Render Time: | 8.81 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1520.69 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


